Vision 2030 is our corporate strategy designed to drive us to become the leading muscle-focused specialty biopharmaceutical company intent on meaningfully improving the lives of patients through global access to innovative medicines.
Vision 2030 articulates our ambitious path to reach the next frontier and advances our pioneering research to benefit patients, shareholders, and employees.
